ResultsIQ

ResultsIQ › Latest results › Relaxo Footwears Limited

Relaxo Footwears Limited Q4 FY25 earnings call summary

NSE: RELAXO · BSE: 530517

Earnings call of 12 May 2025, summarised by AI from the filing.

Relaxo Q4 FY25 revenue ₹695 cr (vs ₹747 cr), FY25 revenue ₹2,790 cr; guides ₹100 cr capex and 1% plus EBITDA margin improvement for FY26.

Key takeaways

  1. Q4 revenue ₹695 cr (Q4 FY24: ₹747 cr), decline due to softer volume amid challenging demand environment.
  2. Capex guidance ₹100 cr planned for next year.
  3. Margin outlook EBITDA margin expected to improve by 1% plus in FY26.
  4. Distribution revamp Shift from primary to secondary sales; DMS and RPA implemented, 100 new distributors targeted.
  5. Demand risk Challenging demand environment, particularly in mid-range footwear segment.

Original filing on BSE

Relaxo Footwears Limited Q1 FY27 results

As filed: Revenue ₹705 cr (+8% year on year), EBITDA ₹108 cr (+8% year on year), PAT ₹54.9 cr (+12% year on year), EBITDA margin 15.4% (+6 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹751 cr (+8% year on year), EBITDA ₹124 cr (+12% year on year), PAT ₹67.7 cr (+21% year on year), EBITDA margin 16.5% (+54 bps). Score 82 of 100, Above trend. Revenue, EBITDA and profit growth were well above the company's own trend. EBITDA margin rose 54 bps year on year. Share price after the results: +36.9% in 28 days (Nifty 500: +0.6%).
  • Q3 FY26: Revenue ₹668 cr (0% year on year), EBITDA ₹69.4 cr (−16% year on year), PAT ₹26.5 cr (−20% year on year), EBITDA margin 10.4% (−206 bps). Score 21 of 100, Below trend. Revenue growth was in line with the company's own trend; EBITDA and profit growth were well below it. EBITDA margin fell 206 bps year on year. Other income 31% of PBT. Profit fell 26% from last quarter. Share price after the results: −8.0% in 28 days (Nifty 500: +0.4%).
  • Q2 FY26: Revenue ₹629 cr (−7% year on year), EBITDA ₹81.0 cr (−8% year on year), PAT ₹36.0 cr (−3% year on year), EBITDA margin 12.9% (−8 bps). Score 33 of 100, Below trend. Revenue growth was well below the company's own trend; EBITDA growth was below it; profit growth was in line with it. EBITDA margin was flat year on year. Revenue fell 4% from last quarter. Share price after the results: −5.7% in 29 days (Nifty 500: −0.4%).
  • Q1 FY26: Revenue ₹654 cr (−13% year on year), EBITDA ₹100 cr (+1% year on year), PAT ₹49.0 cr (+11% year on year), EBITDA margin 15.3% (+206 bps). Score 45 of 100, In line with trend. Revenue growth was well below the company's own trend; EBITDA growth was in line with it; profit growth was above it. EBITDA margin rose 206 bps year on year. Revenue fell 6% from last quarter. Share price after the results: −1.1% in 30 days (Nifty 500: −2.5%).
  • Q4 FY25: Revenue ₹695 cr (−7% year on year), EBITDA ₹111 cr (−8% year on year), PAT ₹56.0 cr (−8% year on year), EBITDA margin 16.0% (−9 bps). Score 32 of 100, Below trend. Revenue growth was well below the company's own trend; EBITDA and profit growth were below it. EBITDA margin was flat year on year. Share price after the results: +11.7% in 28 days (Nifty 500: +6.9%).
  • Q3 FY25: Revenue ₹667 cr (−6% year on year), EBITDA ₹83.0 cr (−6% year on year), PAT ₹33.0 cr (−15% year on year), EBITDA margin 12.4% (+10 bps). Score 32 of 100, Below trend. Revenue growth was well below the company's own trend; EBITDA and profit growth were below it. EBITDA margin rose 10 bps year on year. Profit fell 11% from last quarter.
  • Q2 FY25: Revenue ₹679 cr (−5% year on year), EBITDA ₹88.0 cr (−3% year on year), PAT ₹37.0 cr (−16% year on year), EBITDA margin 13.0% (+23 bps). Score 26 of 100, Below trend. EBITDA margin rose 23 bps year on year. Not enough history for a trend yet: scored on growth alone. Revenue fell 9% from last quarter.

Past price moves after results do not indicate future moves. Not a recommendation.

Relaxo Footwears Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.